Cargando…
P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS.
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431428/ http://dx.doi.org/10.1097/01.HS9.0000971000.57384.96 |
| _version_ | 1785091199568183296 |
|---|---|
| author | Bose, Prithviraj Masarova, Lucia Pemmaraju, Naveen Dobbins, Mackenzie Jain, Nitin Abbas, Hussein Kornblau, Steven Maiti, Abhishek Veletic, Ivo Manshouri, Taghi Bledsoe, Sharon Ann Richie, Mary Hall-Moore, Nakiuda Zhou, Lingsha Wang, Xuemei Kantarjian, Hagop Estrov, Zeev Verstovsek, Srdan |
| author_facet | Bose, Prithviraj Masarova, Lucia Pemmaraju, Naveen Dobbins, Mackenzie Jain, Nitin Abbas, Hussein Kornblau, Steven Maiti, Abhishek Veletic, Ivo Manshouri, Taghi Bledsoe, Sharon Ann Richie, Mary Hall-Moore, Nakiuda Zhou, Lingsha Wang, Xuemei Kantarjian, Hagop Estrov, Zeev Verstovsek, Srdan |
| author_sort | Bose, Prithviraj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314282023-08-17 P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. Bose, Prithviraj Masarova, Lucia Pemmaraju, Naveen Dobbins, Mackenzie Jain, Nitin Abbas, Hussein Kornblau, Steven Maiti, Abhishek Veletic, Ivo Manshouri, Taghi Bledsoe, Sharon Ann Richie, Mary Hall-Moore, Nakiuda Zhou, Lingsha Wang, Xuemei Kantarjian, Hagop Estrov, Zeev Verstovsek, Srdan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431428/ http://dx.doi.org/10.1097/01.HS9.0000971000.57384.96 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bose, Prithviraj Masarova, Lucia Pemmaraju, Naveen Dobbins, Mackenzie Jain, Nitin Abbas, Hussein Kornblau, Steven Maiti, Abhishek Veletic, Ivo Manshouri, Taghi Bledsoe, Sharon Ann Richie, Mary Hall-Moore, Nakiuda Zhou, Lingsha Wang, Xuemei Kantarjian, Hagop Estrov, Zeev Verstovsek, Srdan P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title | P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title_full | P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title_fullStr | P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title_full_unstemmed | P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title_short | P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS. |
| title_sort | p1025: a pilot study of the anti-slamf7 monoclonal antibody, elotuzumab, in patients with myelofibrosis. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431428/ http://dx.doi.org/10.1097/01.HS9.0000971000.57384.96 |
| work_keys_str_mv | AT boseprithviraj p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT masarovalucia p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT pemmarajunaveen p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT dobbinsmackenzie p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT jainnitin p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT abbashussein p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT kornblausteven p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT maitiabhishek p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT veleticivo p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT manshouritaghi p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT bledsoesharon p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT annrichiemary p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT hallmoorenakiuda p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT zhoulingsha p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT wangxuemei p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT kantarjianhagop p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT estrovzeev p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis AT verstovseksrdan p1025apilotstudyoftheantislamf7monoclonalantibodyelotuzumabinpatientswithmyelofibrosis |